Neurawell Therapeutics, Inc. — Form D
Neurawell Therapeutics, Inc. of SUNNY ISLES BEACH, FL, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-10. The offering totals $3.0M, of which $1.6M was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-06-10
- Form: D
- Accession: 0002026298-24-000003
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.6M
- Remaining: $1.4M
- Investors: 4
- Date of first sale: 2024-05-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-515484
Issuer
- Name: Neurawell Therapeutics, Inc.
- CIK: 0002026298
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 18501 COLLINS AVE, #4301, SUNNY ISLES BEACH, FL, 33160
- Phone: 703-472-8714
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Jack Abraham | Director | Sunny Isles Beach, FL |
| Magid Abraham | Director | Sunny Isles Beach, FL |
| Tom Insel | Director | San Francisco, CA |
| Magid Abraham | Executive Officer | Sunny Isles Beach, FL |
| Tom Insel | Executive Officer | San Francisco, CA |
More